Study: Reformulated Imatinib Eliminates Morphine Tolerance

Researchers at the University of Texas MD Anderson Cancer Center have eliminated morphine tolerance in rats by reformulating the common cancer drug imatinib, according to a news release.

Advertisement

Removing morphine tolerance could eliminate the need for increasing doses of painkillers to treat chronic pain. In some cases, patients develop a tolerance so high, the medication stops working altogether. In the study, imatinib not only prevented morphine tolerance but reversed tolerance in rats that received high morphine doses continuously for several days.


Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!

Related Articles on Pain Management:

CDC Report Suggests Use of Antidote Could Have Prevented Opioid Overdose Deaths
American Academy of Pain Medicine: Eliminate Pain as a Major Health Crisis Now
USA Pain Professionals Opens in New Mexico

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.